 |
|
The 'MIP-MAP' game: Indian bug is the ancestor of Crohn's disease pathogen
October 03, 2007An Indian team of researchers led by Seyed E. Hasnain of the Institute of Life Sciences (ILS), University of Hyderabad, India has found that a seemingly unknown mycobacterial organism Mycobacterium indicus pranii (MIP) could be the earliest ancestor of the 'generalist' branch of mycobacterial pathogens. The 'generalist' bacteria infect anything from cockroaches to human and are capable of surviving in soil and water as against human adapted 'specialists' such as tubercle and leprosy bacilli. TB, a disease that killed about 1.7 million humans last year alone, is caused by a member of the Mycobacterial family of pathogens.
The finding further suggests that the prominent 'generalist' pathogen M. avium which seriously haunts AIDS patients, together with its close associate M. avium paratuberculosis (MAP), the agent of Crohn's disease in humans and Johne's disease in cattle descended from the MIP. It was also found that the MIP and the MAP bacilli initially inhabited water bodies and infected marine organisms predated by fishes finally arriving on soil through bird-droppings.
The MIP bacilli, also called as Mycobacterium w (Mw) were first isolated in India by G. P. Talwar at the All India Institute of Medical Sciences, New Delhi, in eighties and it is currently used, after an extensive and perhaps the largest clinical trial in the world, as an immunotherapeutic against leprosy in India. The success with MIP based leprosy vaccine has led to human clinical evaluations of MIP in interventions against HIV-AIDS, psoriasis and bladder cancer in India. MIP, commercially available as 'Immuvac', is currently the focus of advanced multi-centric phase III clinical trials for its antituberculosis efficacy.
The comparative genomics study based on complete sequence of the MIP organism published in October 2, 2007 release of the prestigious open access journal PLoS ONE reports observations based on the first ever whole genome sequencing project from India, carried out jointly by the ILS, the Centre for DNA fingerprinting and Diagnostics also at Hyderabad and the University of Delhi. The study provides an important evolutionary basis for the acquisition and optimization of virulence in mycobacteria and determinants of boundaries therein. Similarly these efforts constitute a step forward in understanding the role of non-pathogenic and saprophytic mycobacteria in immunomodulation and in triggering innate immune responses. The study advocates exploitation of genetic similarity between MIP and MAP as a plausible advantage for therapeutic intervention against Crohn's and Johne's diseases.
Public Library of Science
The comparative genomics study based on complete sequence of the MIP organism published in October 2, 2007 release of the prestigious open access journal PLoS ONE reports observations based on the first ever whole genome sequencing project from India, carried out jointly by the ILS, the Centre for DNA fingerprinting and Diagnostics also at Hyderabad and the University of Delhi. The study provides an important evolutionary basis for the acquisition and optimization of virulence in mycobacteria and determinants of boundaries therein. Similarly these efforts constitute a step forward in understanding the role of non-pathogenic and saprophytic mycobacteria in immunomodulation and in triggering innate immune responses. The study advocates exploitation of genetic similarity between MIP and MAP as a plausible advantage for therapeutic intervention against Crohn's and Johne's diseases.
Public Library of Science
Mycobacterial Current Events and Mycobacterial News RSSCarb synthesis sheds light on promising tuberculosis drug target
A fundamental question about how sugar units are strung together into long carbohydrate chains has also pinpointed a promising way to target new medicines against tuberculosis.
Proteomics Study Yields Clues As To How Tuberculosis Might Be Thwarting The Immune System
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.
UT public health experts discover new information about diabetes' link to tuberculosis
New evidence discovered by researchers at The University of Texas School of Public Health Brownsville Regional Campus shows that patients with Type 2 diabetes may be at increased risk of contracting tuberculosis because of a compromised immune system, resulting in life-threatening lung infections that are more difficult to treat.
Tuberculosis not the only risk from new immunological drugs
A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis.
Scientists find how bacteria in cows milk may cause Crohn's disease
Scientists at the University of Liverpool have found how a bacterium, known to cause illness in cattle, may cause Crohn's disease in humans.
Treatment outcomes of patients with HIV and tuberculosis
In a retrospective study of 700 patients with culture-positive tuberculosis (TB), relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen.
Tuberculosis: The bacillus takes refuge in adipose cells
A team from the Institut Pasteur has recently shown that the tuberculosis bacillus hides from the immune system in its host's fat cells.
Faster, more accurate tuberculosis test developed
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Imperial College London, Universidad Peruana Cayetano Heredia, in Lima, Peru, and other institutions have developed a simple and rapid new tuberculosis (TB) test.
Measuring Biodiversity and More: PLoS Biology Press Release
Biodiversity: measuring up to the loss Species are disappearing faster than biologists can identify and document them. Mindful of this crisis, nearly 200 countries (under the Convention on Biological Diversity) agreed to staunch the loss of biodiversity by 2010. However, to meet this goal, biologists need reliable metrics to monitor global trends in biodiversity. In the open access journal, PLoS Biology, Stuart Butchart from Birdlife International, Cambridge, UK, and others from Conservation International, IUCN and the Institute of Zoology, London, describe a new way to generate such an index that can measure trends in extinction risk for complete classes of organisms, starting with the wo
Unusual carbohydrate structure in the cell walls of tuberculosis bacteria-a new point of attack for drugs?
Even though we have lost much of our fear of tuberculosis in the industrialized countries, according to the WHO about 2 mio. people worldwide die each year of this infectious disease. Researchers at the University of Leeds have now discovered a carbohydrate with an unusual structure in the cell walls of Mycobacterium tuberculosis, the bacterium that causes tuberculosis. This could be a new starting point for pharmaceutical research. The main component of the cell walls of mycobacteria is a lipoarabinomannan (LAM), a molecule consisting of a branched segment made of many sugar building blocks, which is anchored to the cell wall by a fat-like segment. The sugars involved are almost exclusively
More Mycobacterial Current Events and Mycobacterial News Articles
| © 2009 BrightSurf.com |